Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Wedo Venture Partners is a venture capital organization founded in 2016, headquartered in Singapore and Beijing. The firm has assembled a global team of over 10 specialized experts in science, medicine, and business, focusing on the biotechnology and medical technology sectors. Since its inception, Wedo Venture Partners has aimed to empower leaders in these fields by bridging cultural and capital gaps between the East and West.
The organization has achieved notable milestones, including a full exit from its first fund, showcasing strong performance in its investments. Currently, Wedo Venture Partners manages a portfolio of 30 companies, reflecting its commitment to early-stage innovations that enhance human health. The firm operates primarily in Singapore, China, and the United States, positioning itself strategically in key markets for biotech and medtech.
Wedo Venture Partners specializes in investments within the biotechnology and medical technology sectors, targeting early-stage innovations. The firm focuses on pre-seed, seed, seed-plus, and Series A stages, providing capital to entrepreneurs and scientists who encounter market dislocations, cultural barriers, and geopolitical challenges. Their investment strategy emphasizes creating global impact through partnerships, IPOs, and acquisitions that improve health outcomes.
Operating primarily in Singapore, China, and the United States, Wedo Venture Partners seeks to back visionary founders who are addressing critical health issues. The firm looks for teams that demonstrate resilience and adaptability in navigating complex market dynamics, ensuring that their investments align with a mission to enhance human health on a global scale.
Wedo Venture Partners has built a diverse portfolio of 30 companies, focusing on early-stage ventures in the biotech and healthcare sectors. While specific portfolio companies were not detailed in the provided content, the firm has achieved notable success, including a full exit from its first fund, which highlights its strong performance in the market.
The firm’s investment strategy is designed to support companies that are innovating in health outcomes, particularly those that can overcome cultural and geopolitical barriers. This approach positions Wedo Venture Partners as a key player in the global biotech and medtech landscape.
Xiaopeng Summer Qu - Founding Partner. Xiaopeng has extensive experience in venture capital and has led multiple successful investments in the biotech sector.
Dr. Xinhong Lim - Partner. Dr. Lim brings a strong background in medical technology and has been instrumental in guiding portfolio companies through early-stage development.
Mu Ni - Partner. Mu has a solid track record in investment management and focuses on identifying promising biotech startups.
Yun Sam Wu - Venture Partner. Yun Sam has expertise in cross-border investments, particularly between Asia and the United States.
Xiaomeng Marina Guo - M.D. Xiaomeng provides medical insights and guidance to portfolio companies, enhancing their strategic direction.
Hui Kang - M.D. Hui contributes clinical expertise, helping startups navigate regulatory challenges in the healthcare sector.
Leilei Wang - M.D. Leilei focuses on medical technology investments and supports portfolio companies in product development.
Heng Flora Li - M.D. Heng brings a wealth of knowledge in healthcare innovation and assists in evaluating investment opportunities.
Dong Chen - E.D. Dong plays a key role in operational management and strategic planning for the firm.
Baikuan Clint Guo - E.D. Baikuan focuses on investment analysis and portfolio management, ensuring alignment with the firm’s goals.
Mengmeng Du - V.P. Mengmeng supports deal sourcing and due diligence processes, contributing to the firm’s investment strategy.
To pitch Wedo Venture Partners, founders should visit their website at wedo.vc. It is advisable to include a clear overview of the business model, market opportunity, and team qualifications in the pitch deck. Specific response time expectations were not provided.
As of 2023, Wedo Venture Partners has successfully exited its first fund, demonstrating strong performance in the biotech and healthcare sectors. This achievement highlights the firm's ability to identify and support promising early-stage companies.
Wedo Venture Partners continues to expand its portfolio, focusing on innovative startups that address critical health challenges. The firm remains active in seeking new investment opportunities in biotechnology and medical technology.
What are Wedo Venture Partners' investment criteria?
Wedo Venture Partners invests in early-stage companies within the biotechnology and medical technology sectors. They focus on pre-seed, seed, seed-plus, and Series A stages, targeting entrepreneurs and scientists who face market dislocations and cultural barriers.
How can I apply or pitch to Wedo Venture Partners?
Founders can pitch to Wedo Venture Partners by visiting their website at wedo.vc. Specific application forms or email addresses were not provided, but the website serves as the primary channel for submissions.
What makes Wedo Venture Partners different from other VC firms?
The firm emphasizes bridging cultural and capital gaps between the East and West, focusing on global impact through partnerships and innovative health solutions. Their team comprises experts in science, medicine, and business, providing a unique perspective on investments.
What is the geographic scope of Wedo Venture Partners?
Wedo Venture Partners primarily operates in Singapore, China, and the United States, allowing them to tap into key markets for biotech and medtech innovations.
What is the typical check size for investments?
While specific check sizes were not disclosed, Wedo Venture Partners focuses on early-stage investments, which typically range from pre-seed to Series A funding rounds.
What kind of post-investment involvement does Wedo Venture Partners have?
The firm aims for global impact and outcomes, planning for IPOs, acquisitions, and partnerships that create value and improve health. Their involvement likely includes strategic guidance and support for portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.